Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Kiniksa Pharmaceuticals Ltd
Income from Continuing Operations
Kiniksa Pharmaceuticals Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
Income from Continuing Operations
$8.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Kiniksa Pharmaceuticals Ltd's Income from Continuing Operations?
Income from Continuing Operations
8.6m
USD
Based on the financial report for Mar 31, 2024, Kiniksa Pharmaceuticals Ltd's Income from Continuing Operations amounts to 8.6m USD.
What is Kiniksa Pharmaceuticals Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
-96%
Over the last year, the Income from Continuing Operations growth was -96%.